World's Best Scientists 2026 revealed!
Human Psychopharmacology
H-index 12

Human Psychopharmacology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Psychology 733 38 37 9
Medicine 2668 40 36 8

Additional Metrics

Number of Best Scientists*: 100
Documents by Best Scientists*: 71
Top 100 Ranked Scientists*: 3
SCIMAGO H-index: 87
SCIMAGO SJR: 0.51
Impact Factor: 1.7

Overview

Top Research Topics at Human Psychopharmacology-clinical and Experimental?

The journal investigates studies in Psychiatry, Internal medicine, Anesthesia, Placebo and Pharmacology. Most of the works presented in Human Psychopharmacology-clinical and Experimental deals with Psychiatry but it intersects with the subject of Clinical psychology. Internal medicine research presented in Human Psychopharmacology-clinical and Experimental encompasses a variety of subjects, including Antidepressant, Endocrinology, Gastroenterology and Schizophrenia.

It aims to address concerns in Schizophrenia, specifically in the areas of Antipsychotic, Risperidone, Clozapine and Positive and Negative Syndrome Scale. Topics in Placebo were tackled in line with various other fields like Randomized controlled trial and Audiology. The journal investigates Audiology research which frequently intersects with Developmental psychology.

The study on Pharmacology presented is investigated in conjunction with research in Serotonin. Serotonergic is a focus of the Serotonin works in the journal.

  • Psychiatry (29.65%)
  • Internal medicine (24.32%)
  • Anesthesia (15.05%)

What are the most cited papers published in the journal?

  • Circadian rhythm disturbances in depression. (383 citations)
  • Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. (363 citations)
  • Cannabis and anxiety: a critical review of the evidence (311 citations)

Research areas of the most cited articles at Human Psychopharmacology-clinical and Experimental:

The published papers investigate studies in Psychiatry, Placebo, Internal medicine, Anesthesia and Pharmacology. The featured Psychiatry studies in the most cited papers mainly concentrate on Clinical psychology but also cover areas of interest in Young adult. The Placebo research presented in the most cited publications focuses mostly on Randomized controlled trial and, on occasion, topics in Clinical trial.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Psychiatry
  • Pharmacology

The previous edition focused in particular on these issues:

The topics of Internal medicine, Placebo, Depression (differential diagnoses), Adverse effect and Cognition are the focal point of discussions in the journal. Topics in Internal medicine explored in it were investigated in conjunction with research in Clinical Global Impression, Schizophrenia, Positive and Negative Syndrome Scale, Rating scale and Antidepressant. Interference theory, Anesthesia, Meta-analysis and Recall are some topics wherein Placebo research discussed in it have an impact.

Human Psychopharmacology-clinical and Experimental facilitates discussions on Depression (differential diagnoses) that incorporate concepts from other fields like Ecological study, Observational study and Obstetrics. The research on Cognition tackled can also make contributions to studies in the areas of Caffeine and Audiology. It focused on Amisulpride research conducted under the discipline of Psychiatry.

The most cited articles from the last journal are:

  • Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial (4 citations)
  • Is short-term antidepressant treatment effective and safe in bipolar depression? Results from an observational multicenter study. (2 citations)
  • Driving performance and neurocognitive skills of long-term users of sedating antidepressants. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Human Psychopharmacology-clinical and Experimental (based on the number of publications) are:

  • Brian E. Leonard (123 papers) absent at the last edition,
  • Ian Hindmarch (70 papers) absent at the last edition,
  • David S. Baldwin (33 papers) absent at the last edition,
  • Fabrizio Schifano (31 papers) absent at the last edition,
  • Andrew C. Parrott (31 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Human Psychopharmacology-clinical and Experimental (based on the number of publications) are:

  • National University of Ireland, Galway (136 papers) absent at the last edition,
  • University of Surrey (64 papers) absent at the last edition,
  • Swinburne University of Technology (58 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • University of Melbourne (52 papers) absent at the last edition,
  • University of Hertfordshire (49 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 0.00% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 10.34% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.17% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.97% of all publications and 65.52% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Psychopharmacology

The field of psychopharmacology provides a variety of fascinating career opportunities. Researchers and mental health professionals can utilize their knowledge in pharmacology to diagnose and treat mental illnesses. Practitioners in this field can work in hospitals, government agencies, non-profit organizations, or private sectors contributing to both clinical practice and extensive research. A specialized application of this field is demonstrated by Board Certified Behavior Analysts (BCBAs) who apply the principles of behavior analysis and psychopharmacology for the treatment and management of neurodevelopmental disorders such as Autism Spectrum Disorder. For those who aspire to pursue a career in this domain, obtaining professional certification can enhance their expertise and professional credibility. If you are interested in learning more about this profession, you can take a look at how to become a board certified behavior analyst in Kansas. The link provides a comprehensive guide on the pathways to become a BCBA, along with the requisite education, certification, and other requirements. In conclusion, a career in psychopharmacology can be a highly rewarding option to consider for those who are interested in human health and medical research.

Top Publications

  • Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression

    (2022)
    36 Citations
  • A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans

    Elisabeth Prevete;Kim Paula Colette Kuypers;Eef Lien Theunissen;Ornella Corazza;Ornella Corazza

    (2021)
    34 Citations
  • Structured review of the use of the Arizona sexual experiences scale in clinical settings.

    Hesham Y Elnazer;David S Baldwin

    (2020)
    28 Citations
  • Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized, placebo‐controlled trials

    (2022)
    23 Citations
  • Ayahuasca may help to improve self-compassion and self-criticism capacities.

    Elisabet Domínguez-Clavé;Joaquim Soler;Matilde Elices;Alba Franquesa

    (2021)
    20 Citations
  • How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy.

    Laura Orsolini;Stefania Chiappini;Duccio Papanti;Roberto Latini

    (2020)
    20 Citations
  • Potential processes of change in MDMA-Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self-transcendence, and therapeutic relationships.

    Jason B. Luoma;Ben Shahar;M. Kati Lear;Brian Pilecki

    (2021)
    17 Citations
  • Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings

    Daria Piacentino;Daria Piacentino;Gabriele Sani;Georgios D. Kotzalidis;Simone Cappelletti

    (2021)
    17 Citations
  • Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea

    (2022)
    16 Citations
  • The effect of cannabidiol on simulated car driving performance: A randomised, double-blind, placebo-controlled, crossover, dose-ranging clinical trial protocol.

    Danielle McCartney;Melissa J. Benson;Anastasia S. Suraev;Christopher Irwin

    (2020)
    14 Citations

Related Online Degrees & Career Pathways

For students interested in healthcare beyond traditional medicine, exploring related online degrees can open diverse career opportunities. Programs like a kinesiology online degree offer a strong foundation in human movement and physical therapy, ideal for those passionate about rehabilitation and sports medicine.

Nurses aiming to advance their clinical expertise may consider accelerated options such as the 1 year pmhnp program, which prepares students for psychiatric-mental health nurse practitioner roles in a relatively short timeframe.

Similarly, a shortest post masters fnp program supports family nurse practitioners looking to enhance their credentials and expand their scope of practice efficiently.

Nutrition is another vital healthcare area. Pursuing an online dietitian degree can lead to careers focused on diet planning, wellness, and preventive care, complementing medical knowledge with specialized nutrition expertise.

Best Scientists Contributing to This Journal